Literature DB >> 17127417

The role of B cells in animal models of rheumatoid arthritis.

Shannon K O'Neill1, Tibor T Glant, Alison Finnegan.   

Abstract

Rheumatoid arthritis is a chronic systemic inflammatory autoimmune disease that affects approximately 1% of the population. Recent studies demonstrate a significant improvement in clinical symptoms in patients treated with Rituximab, an anti-CD20 monoclonal antibody that depletes pro-B cells and mature B cells but not plasma cells. These findings indicate that B cells are an important contributor to the pathogenesis of RA. In this review we will examine the role of B cells in several different murine models of RA. There are a number of antibody-dependent mechanisms by which B cells support inflammatory processes in the joint. However, there are also antibody-independent mechanisms that involve B cell/T cell collaboration where B cells may modulate autoreactive T cell responses. In addition, B cells may be an important source of cytokines that either stimulate or inhibit autoimmune responses. Understanding the role of B cells in RA will provide new and directed therapeutic approaches to the treatment of disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17127417     DOI: 10.2741/2184

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  14 in total

1.  CD23+ CD21(high) CD1d(high) B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential.

Authors:  Safiehkhatoon Moshkani; Igor I Kuzin; Funmilola Adewale; Johan Jansson; Iñaki Sanz; Edward M Schwarz; Andrea Bottaro
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

2.  Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy.

Authors:  Jie Li; Igor Kuzin; Safiehkhatoon Moshkani; Steven T Proulx; Lianping Xing; Denise Skrombolas; Robert Dunn; Iñaki Sanz; Edward M Schwarz; Andrea Bottaro
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

3.  T cell receptor (TCR) signal strength controls arthritis severity in proteoglycan-specific TCR transgenic mice.

Authors:  K Olasz; F Boldizsar; K Kis-Toth; O Tarjanyi; A Hegyi; W van Eden; T A Rauch; K Mikecz; T T Glant
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

4.  Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID mice.

Authors:  Katalin Kis-Toth; Marianna Radacs; Katalin Olasz; Willem van Eden; Katalin Mikecz; Tibor T Glant
Journal:  Int Immunol       Date:  2012-04-19       Impact factor: 4.823

5.  Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome.

Authors:  Wen-Wu Li; Tian-Zhi Guo; Xiaoyou Shi; Eva Czirr; Trisha Stan; Peyman Sahbaie; Tony Wyss-Coray; Wade S Kingery; J David Clark
Journal:  Pain       Date:  2014-09-10       Impact factor: 6.961

Review 6.  Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis.

Authors:  A Hanyecz; K Olasz; O Tarjanyi; P Nemeth; K Mikecz; T T Glant; F Boldizsar
Journal:  Biomed Res Int       Date:  2014-01-29       Impact factor: 3.411

7.  Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response.

Authors:  Magda Nakou; Georgios Katsikas; Prodromos Sidiropoulos; George Bertsias; Eva Papadimitraki; Amalia Raptopoulou; Helen Koutala; Helen A Papadaki; Herakles Kritikos; Dimitrios T Boumpas
Journal:  Arthritis Res Ther       Date:  2009-08-28       Impact factor: 5.156

8.  Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort.

Authors:  Jacques-Eric Gottenberg; Corinne Miceli-Richard; Béatrice Ducot; Philippe Goupille; Bernard Combe; Xavier Mariette
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

9.  Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis.

Authors:  Gianfranco Ferraccioli; Barbara Tolusso; Francesca Bobbio-Pallavicini; Elisa Gremese; Viviana Ravagnani; Maurizio Benucci; Edoardo Podestà; Fabiola Atzeni; Alice Mannocci; Domenico Biasi; Mariangela Manfredi; Piercarlo Sarzi-Puttini; Bruno Laganà; Carlomaurizio Montecucco
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

10.  Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats.

Authors:  Innocenzo Caruso; Salvatore Santandrea; Mariarita Gismondo; Alessandra Lombardi; Franco Montrone; Enzo Massimo Caruso; Piercarlo Sarzi Puttini
Journal:  J Transl Med       Date:  2016-06-07       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.